AI Verdict
Both stocks have similar AI ratings. Review detailed metrics below.
MBX vs MBIO Fundamental Comparison
| Metric | MBX | MBIO |
|---|---|---|
| Revenue | N/A | $0.0 |
| Net Income | $-87.0M | $-1.9M |
| Net Margin | N/A | N/A |
| ROE | -23.6% | -20.2% |
| ROA | -22.6% | -10.9% |
| Current Ratio | 24.62x | 2.22x |
| Debt/Equity | 0.00x | 1.65x |
| EPS | $-2.38 | $-0.39 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
MBX vs MBIO: Frequently Asked Questions
Is MBX or MBIO a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), both stocks have similar ratings. MBX is rated STRONG SELL (92% confidence) while MBIO is rated STRONG SELL (92% confidence). This is not investment advice.
How does MBX compare to MBIO fundamentally?
MBX Biosciences, Inc. has ROE of -23.6% vs MUSTANG BIO, INC.'s -20.2%. Net margins are N/A vs N/A respectively.
Which stock pays higher dividends, MBX or MBIO?
MBX has a dividend yield of N/A or no dividend while MBIO has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in MBX or MBIO for long term?
For long-term investing, consider that MBX has STRONG SELL rating with 92% confidence, while MBIO has STRONG SELL rating with 92% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about MBX vs MBIO?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For MBX vs MBIO, both AIs rate them similarly based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.